Zealand Pharma — Maj 2025

[Svingtraderen]

****ZEALAND PHARMA/DANSKE BANK: GENOPTAGES MED "KØB"

[SEACOP]

Danske Bank: "We reinitiate coverage of Zealand Pharma with a 12M target price of DKK800 and a Buy recommendation. We base this on the value of Zealand’s obesity portfolio, which we find very promising, coupled with strong partnerships that increase the likelihood of a meaningful market presence."

[Stockwatch1]

Danske Bank: The Roche partnership, coupled with the share declining more than
50% from its peak in June 2024, causes us to find material upside potential in the
current share valuation and our 12M target price of DKK800. We identify upside
potential in our valuation to a share price of DKK1,350.

[Svingtraderen]

tak

[Helge_LarsenPI-redaktør]

Danske Bank ser kæmpe potentiale i Zealand Pharma-aktien og siger "køb" https://proinvestor.com/investornyt/1321266/danske-bank-ser-kaempe-potentiale-i-zealand-pharma-aktien-og-siger-kob

[Stockwatch1]

Investor om Zealand: “Alt under kurs 800 er et godt opkøbsniveau”

Investor om Zealand: “Alt under kurs 800 er et godt opkøbsniveau”Zealand Pharma sendes højt op i aktiehandlen mandag efter en positiv analyse fra Danske Bank. Banken har indledt sin dækning af det dan

borsen.dk (borsen.dk)

[Stockwatch1]

Investor om Zealand: “Alt under kurs 800 er et godt opkøbs­ni­veau”

[ProinvestorNEWS]

OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1321372/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

[LP90]

Godmorgen så er det den mest shortede aktie i DK næsten 10% vildt

[ProinvestorNEWS]

Aktier/tendens: Novo, DSV og Zealand kan rammes af ny vægtning i ventet flad åbning https://proinvestor.com/investornyt/1321376/aktier-tendens-novo-dsv-og-zealand-kan-rammes-af-ny-vaegtning-i-ventet-flad-abning

[ProinvestorNEWS]

Maj Status: NVIDIA, toldsatser, Novo, Zealand Pharma, Gubra, Genmab, Embla Kort video: https://proinvestor.com/boards/126575